{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:45:22Z","timestamp":1778028322522,"version":"3.51.4"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Germ cell tumors with somatic malignant transformation (GCT with SMT) are rare in children and poorly described. Data are missing to determine if therapies should target the GCT, the SMT compound, or both simultaneously.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients and Methods:<\/jats:title>\n            <jats:p>A retrospective national study was conducted in the Soci\u00e9t\u00e9 Fran\u00e7aise des cancers de l\u2019Enfant (SFCE) Centers. Medical records from patients aged 0 to 18 years diagnosed with GCT with SMT between 2000 and 2015 were analyzed. Any stages and primary sites were considered as well as synchronous and metachronous cases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Fifteen patients were identified. Thirteen patients had synchronous GCT with SMT. In the latter cases, primaries were ovary (5), mediastinum (3), pineal gland (3), sacrococcyx (1), and parametrium (1). SMT histologies were central primitive neuroectodermal tumor (5), embryonal rhabdomyosarcomas (3) or thyroid papillary adenocarcinoma, leukemia, poorly differentiated carcinoma, mixed sarcomas, and miscellaneous histology (1 case each). Chemotherapy was targeted against the GCT (3), the SMT (6), or both components (3). The last patient received surgery exclusively. Partial or complete response to chemotherapy was observed in 5\/10 assessable cases: 2\/3 patients treated with GCT-dedicated chemotherapy, 3\/6 patients treated with SMT-dedicated therapy, and 0\/1 treated with combined therapy. In addition, 2 patients with mediastinal GCT primary had metachronous SMT, with acute myeloid leukemia and thyroid papillary adenocarcinoma, 8 months and 8 years, respectively, after the diagnoses of GCT. Two patients (1 synchronous and 1 metachronous) were cured with surgery exclusively. At the end of follow-up, 6 patients died of their disease including all 4 with postsurgical macroscopic residue.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>GCT with SMT constitutes a very rare entity in children and adolescents. Surgical removal of the tumor is the cornerstone of the treatment and might be sufficient in selected cases. In the remaining cases, the best management is still unknown and should take into account both components and their respective chemosensitivity. Long-term surveillance is advised for patient with unresected teratoma as late transformation can occur.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mph.0000000000000823","type":"journal-article","created":{"date-parts":[[2017,4,12]],"date-time":"2017-04-12T14:11:21Z","timestamp":1492006281000},"page":"388-394","source":"Crossref","is-referenced-by-count":14,"title":["Two Tumors in 1: What Should be the Therapeutic Target? Pediatric Germ Cell Tumor With Somatic Malignant Transformation"],"prefix":"10.1097","volume":"39","author":[{"given":"Cecile","family":"Faure Conter","sequence":"first","affiliation":[{"name":"Institute of Pediatric Hematology and Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brice","family":"Fresneau","sequence":"additional","affiliation":[{"name":"Department of Child and Adolescent Cancer, Gustave Roussy Cancer Institute, Villejuif"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estelle","family":"Thebaud","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, University Hospital Center of Nantes, Nantes"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amandine","family":"Bertrand","sequence":"additional","affiliation":[{"name":"Institute of Pediatric Hematology and Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederique","family":"Dijoud","sequence":"additional","affiliation":[{"name":"Department of Pathology, Women and Children\u2019s Hospital, Lyon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelique","family":"Rome","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology of Timone Children\u2019s Hospital, Marseille"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecile","family":"Dumesnil","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, University Hospital Center of Rouen, Rouen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Pierre","family":"Castex","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Children\u2019s Hospital, Toulouse"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anguella","family":"Ghanem","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Lebanese Hospital, University Medical Center, Beirut, Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Orbach","sequence":"additional","affiliation":[{"name":"Department of Pediatric, Adolescents, Young Adults, Institut Curie, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/1097-0142(19841101)54:9<1824::AID-CNCR2820540910>3.0.CO;2-J","article-title":"The development of non-germ cell malignancies within germ cell tumors. A clinicopathologic study of 11 cases","volume":"54","author":"Ulbright","year":"1984","journal-title":"Cancer"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1097\/PAS.0000000000000262","article-title":"\u2018Somatic-type\u2019 malignancies arising from testicular germ cell tumors: a clinicopathologic study of 124 cases with emphasis on glandular tumors supporting frequent yolk sac tumor origin","volume":"38","author":"Magers","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJM199005173222004","article-title":"Hematologic neoplasia associated with primary mediastinal germ-cell tumors","volume":"322","author":"Nichols","year":"1990","journal-title":"N Engl J Med"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/pbc.22079","article-title":"Sacrococcygeal Immature Teratoma With Malignant Ependymoma Component","volume":"53","author":"Busse","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.eururo.2006.10.021","article-title":"Chemotherapy in Patients with Teratoma with Malignant Transformation","volume":"51","author":"El Mesbahi","year":"2007","journal-title":"Eur Urol"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/pbc.24730","article-title":"Salvage therapy for refractory or recurrent pediatric germ cell tumors: The french SFCE experience","volume":"61","author":"Faure-Conter","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.suronc.2012.03.001","article-title":"Prognosis of malignant sacrococcygeal germ cell tumours according to their natural history and surgical management","volume":"21","author":"Baranzelli","year":"2012","journal-title":"Surg Oncol"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer Elsevier Ltd"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijgo.2007.11.004","article-title":"History of the FIGO cancer staging system","volume":"101","author":"Odicino","year":"2008","journal-title":"Int J Gynecol Obstet"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1148\/93.6.1351","article-title":"An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas","volume":"93","author":"Chang","year":"1969","journal-title":"Radiology"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.suronc.2012.03.001","article-title":"Prognosis of malignant sacrococcygeal germ cell tumours according to their natural history and surgical management","volume":"21","author":"De Corti","year":"2012","journal-title":"Surg Oncol Elsevier Ltd"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric-Estimation from Incomplete Observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1097\/PAS.0b013e318033c7c4","article-title":"Germ cell tumors with sarcomatous components: a clinicopathologic and immunohistochemical study of 46 cases","volume":"31","author":"Malagon","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/PAS.0b013e3181adb9d7","article-title":"Testicular germ cell tumors with sarcomatous components: an analysis of 33 cases","volume":"33","author":"Guo","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0022-5347(01)64035-7","article-title":"Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumors","volume":"159","author":"Motzer","year":"1998","journal-title":"J Urol"},{"key":"R17-20230918","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0022-5347(01)63754-6","article-title":"Prognostic features of teratomas with malignant transformation: a clinicopathological study of 21 cases","volume":"159","author":"Comiter","year":"1998","journal-title":"J Urol"},{"key":"R18-20230918","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/S0022-5347(05)66339-2","article-title":"Germ cell tumor associated primitive neuroectodermal tumors","volume":"165","author":"Ganjoo","year":"2001","journal-title":"J Urol"},{"key":"R19-20230918","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1200\/JCO.2003.01.019","article-title":"Chemotherapy for teratoma with malignant transformation","volume":"21","author":"Donadio","year":"2003","journal-title":"J Clin Oncol"},{"key":"R20-20230918","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/j.1464-410X.2010.09705.x","article-title":"Towards the definition of the best management and prognostic factors of teratoma with malignant transformation: A single-institution case series and new proposal","volume":"107","author":"Necchi","year":"2011","journal-title":"BJU Int"},{"key":"R21-20230918","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1093\/annonc\/mdq045","article-title":"Outcome analysis of patients with transformed teratoma to primitive neuroectodermal tumor","volume":"21","author":"Ehrlich","year":"2010","journal-title":"Ann Oncol"},{"key":"R22-20230918","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/COC.0b013e31829d1ed7","article-title":"Metastatic Malignant Transformation of Teratoma to Primitive Neuroectodermal Tumor (PNET): Results With PNET-based Chemotherapy","volume":"38","author":"Al-Hader","year":"2015","journal-title":"Am J Clin Oncol"},{"key":"R23-20230918","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.juro.2014.05.118","article-title":"Management of Germ Cell Tumors with Somatic Type Malignancy: Pathological Features, Prognostic Factors and Survival Outcomes","volume":"192","author":"Rice","year":"2014","journal-title":"J Urol"},{"key":"R24-20230918","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.juro.2015.12.082","article-title":"Treatment and clinical outcomes of patients with teratoma with somatic-type malignant transformation: an International collaboration","volume":"196","author":"Giannatempo","year":"2015","journal-title":"J Urol"},{"key":"R25-20230918","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S1470-2045(08)70306-1","article-title":"Squamous-cell carcinoma in mature cystic teratoma of the ovary: systematic review and analysis of published data","volume":"9","author":"Hackethal","year":"2008","journal-title":"Lancet Oncol"},{"key":"R26-20230918","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/neup.12140","article-title":"Adenocarcinoma arising from intracranial recurrent mature teratoma and featuring mutated KRAS and wild-type BRAF genes","volume":"35","author":"Kim","year":"2015","journal-title":"Neuropathology"},{"key":"R27-20230918","first-page":"61","article-title":"Medulloblastoma arising from an immature teratoma of the posterior fossa. Case report","volume":"106","author":"Das","year":"2007","journal-title":"J Neurosurg"},{"key":"R28-20230918","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1055\/s-2006-942272","article-title":"Teratoma with malignant transformation: Experiences of the cooperative GPOH Protocols MAKEI 83\/86\/89\/96","volume":"218","author":"Biskup","year":"2006","journal-title":"Klin Padiatr"},{"key":"R29-20230918","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/pbc.22397","article-title":"Teratoma with a malignant somatic component in pediatric patients: The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) experience","volume":"54","author":"Terenziani","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"R30-20230918","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/(SICI)1098-2264(199906)25:2<134::AID-GCC9>3.0.CO;2-Y","article-title":"Chromosome Abnormalities of Eighty-One Pediatric Germ Cell Tumors: Sex-, Age-, Site-, and Histopathology-Related Differences\u2014A Children\u2019 s Cancer Group Study","volume":"146","author":"Bussey","year":"1999","journal-title":"Genes Chromosomes Cancer"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00043426-201707000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T04:12:00Z","timestamp":1695010320000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201707000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000000823","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]}}}